A single-center review of outcomes between COVID-19 vaccinated and unvaccinated liver transplant recipients.

Annelise NolanMelissa McGowanLauren Von SteinAdrienne RossManjit KaurTodd PesaventoPriyamvada Singh

Published in: Clinical transplantation (2023)

In a series with a large percentage of UNVAX patients, LTx appears to be safe, with no difference in the rate of COVID-19 or transplant-related outcomes compared to VAX. While we encourage vaccination to prevent severe COVID, based on our results, vaccine status should not be reason to deny lifesaving transplant.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
respiratory syndrome coronavirus
prognostic factors
adipose tissue
drug induced
weight loss